scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0960-9776(09)70283-8 |
P698 | PubMed publication ID | 19914553 |
P50 | author | Roberto Orecchia | Q105532303 |
Giovanni Battista Ivaldi | Q57616823 | ||
P2093 | author name string | Maria Cristina Leonardi | |
P2860 | cites work | IORT for early breast cancer: a report on long-term results | Q73603963 |
IORT in breast carcinomas | Q73603969 | ||
Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial | Q74423012 | ||
Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients | Q74523082 | ||
Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study | Q75221064 | ||
Why and how to combine chemotherapy and radiation therapy in breast cancer patients | Q77936465 | ||
Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience | Q79168857 | ||
Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial | Q79691800 | ||
Impact on outcome of delay in starting radiotherapy | Q79840820 | ||
Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 procedures | Q80171681 | ||
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial | Q80495823 | ||
Effect of external boost volume in breast-conserving therapy on local control with long-term follow-up | Q80594038 | ||
Chemotherapy and radiation therapy for breast cancer: what is the optimal sequence? | Q81011769 | ||
The Salzburg concept of intraoperative radiotherapy for breast cancer: results and considerations | Q82100307 | ||
A dosimetric comparison of IORT techniques in limited-stage breast cancer | Q83351847 | ||
Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival | Q83963177 | ||
Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis | Q33861700 | ||
Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review | Q35057465 | ||
Intraopertive radiation therapy for breast cancer | Q35677782 | ||
A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer | Q35963730 | ||
Intraoperative electrons | Q36089125 | ||
Lessons of studies of breast-conserving therapy with and without whole-breast irradiation for patient selection for partial-breast irradiation | Q36089151 | ||
Eleven-year follow-up results in the delay of breast irradiation after conservative breast surgery in node-negative breast cancer patients | Q36295775 | ||
Delaying radiotherapy for the delivery of adjuvant chemotherapy in the combined modality treatment of early breast cancer: is it disadvantageous and could combined treatment be the answer? | Q36444755 | ||
Moving to a high-tech approach to the irradiation of early breast cancer: is it possible to balance efficacy, morbidity and resource use? | Q36444763 | ||
Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery | Q36694808 | ||
Evidence based radiation oncology: breast cancer | Q36864222 | ||
Implications of the density of clonogenic infestation in radiotherapy | Q39743755 | ||
Effect of delay in initiating radiotherapy for patients with early stage breast cancer | Q40532643 | ||
Mixing anthracyclines and radiotherapy in early breast cancer: how safe is it? | Q41243728 | ||
Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women. | Q43898746 | ||
A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results | Q43978313 | ||
Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer | Q44026297 | ||
Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial | Q44401637 | ||
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial | Q46387542 | ||
Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group | Q46538580 | ||
Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8-10, 2002. | Q47226130 | ||
Breast conservative treatment in association with implant augmentation and intraoperative radiotherapy. | Q51188466 | ||
The validity of surgical clips as a radiographic surrogate for the lumpectomy cavity in image-guided accelerated partial breast irradiation. | Q51612760 | ||
The effect of delay in treatment on local control by radiotherapy. | Q52314322 | ||
Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results. | Q53260246 | ||
The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. | Q53518797 | ||
Breast boost: are we missing the target? | Q53659756 | ||
Effect of Addition of Adjuvant Paclitaxel on Radiotherapy Delivery and Locoregional Control of Node-Positive Breast Cancer: Cancer and Leukemia Group B 9344 | Q57578514 | ||
Conservative treatment of breast cancer--where should the booster dose go? | Q68258233 | ||
Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence | Q71067095 | ||
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of f | Q71197308 | ||
The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy | Q72181300 | ||
Clips and scar as the guidelines for breast radiation boost after lumpectomy | Q73097484 | ||
Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France | Q73132146 | ||
P921 | main subject | intraoperative radiation therapy | Q3928881 |
P304 | page(s) | S98-102 | |
P577 | publication date | 2009-10-01 | |
P1433 | published in | The Breast | Q7719928 |
P1476 | title | Integrated breast conservation and intraoperative radiation therapy | |
P478 | volume | 18 Suppl 3 |
Q34798557 | Intraoperative full-dose of partial breast irradiation with electrons delivered by standard linear accelerators for early breast cancer |
Q37947884 | Intraoperative radiation therapy: is it a standard now? |
Q37392462 | Partial breast irradiation techniques in early breast cancer |
Q38086807 | Research opportunities in intraoperative radiation therapy: the next decade 2013-2023. |
Search more.